story of the week
LDL Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Circulation 2017 Nov 13;[EPub Ahead of Print], MP Bonaca, P Nault, RP Giugliano, AC Keech, AL Pineda, E Kanevsky, J Kuder, SA Murphy, JW Jukema, BS Lewis, L Tokgozoglu, R Somaratne, PS Sever, TR Pedersen, MS SabatineFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.